A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication

Vascular Medicine

Volumn 15, Issue 3, 2010, Pages 181-188

  Pande, Reena L ^a   Hiatt, William R ^b   Zhang, Peter ^c   Hittel, Norbert ^d   Creager, Mark A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^d Otsuka Frankfurt Research Institute GmbH   (Germany)

Author keywords

Intermittent claudication; Peripheral artery disease

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILOSTAZOL; PLACEBO;

ARTERY DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETES MELLITUS; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG USE; HEART INFARCTION; HUMAN; HYPERTENSION; INTERMITTENT CLAUDICATION; META ANALYSIS; MORTALITY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT RESPONSE; WALKING;

HUMANS; INTERMITTENT CLAUDICATION; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TETRAZOLES; THERAPEUTICS; VASODILATOR AGENTS;

EID: 77952573883     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X10361545     Document Type: Article

References (24)

1. Tanaka T., Ishikawa T., Hagiwara M., Onoda K., Itoh H., Hidaka H. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology 1988 ; 36: 313-320.
2. Oida K., Ebata K., Kanehara H., Suzuki J., Miyamori I. Effect of cilostazol on impaired vasodilatory response of the brachial artery to ischemia in smokers. J Atheroscler Thromb 2003 ; 10: 93-98.
3. Igawa T., Tani T., Chijiwa T., et al. Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells. Thromb Res 1990 ; 57: 617-623.
4. Woo SK, Kang WK, Kwon KI Pharmacokinetic and pharmacodynamic modeling of the antiplatelet and cardiovascular effects of cilostazol in healthy humans. Clin Pharmacol Ther 2002 ; 71: 246-252.
5. Beebe HG, Dawson DL, Cutler BS, et al. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial. Arch Intern Med 1999 ; 159: 2041-2050.
6. Strandness DE Jr, Dalman RL, Panian S., et al. Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study. Vasc Endovascular Surg 2002 ; 36: 83-91.
7. Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med 2000 ; 109: 523-530.
8. Dawson DL, Cutler BS, Meissner MH, Strandness DE Jr. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 1998 ; 98: 678-686.
9. Money SR, Herd JA, Isaacsohn JL, et al. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg 1998 ; 27: 267-274 ; discussion 74-75.
10. Elam MB, Heckman J., Crouse JR, et al. Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication. Arterioscler Thromb Vasc Biol 1998 ; 18: 1942-1947.
11. Thompson PD, Zimet R., Forbes WP, Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol 2002 ; 90: 1314-1319.
12. Regensteiner JG, Ware JE Jr, McCarthy WJ, et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc 2002 ; 50: 1939-1946.
13. Robless P., Mikhailidis DP, Stansby GP Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev 2008 (1). CD003748.
14. Packer M., Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991 ; 325: 1468-1475.
15. Hiatt WR, Money SR, Brass EP Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects). J Vasc Surg 2008 ; 47 (2). 330-336.
16. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 ; 30 (6). 473-483.
17. Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. J Vasc Med Biol 1990 ; 2: 142-152.
18. McDermott MM, Liu K., Guralnik JM, Martin GJ, Criqui MH, Greenland P. Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease. J Vasc Surg 1998 ; 28: 1072-1081.
19. Labs KH, Nehler MR, Roessner M., Jaeger KA, Hiatt WR Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol. Vasc Med 1999 ; 4: 239-246.
20. Watson CJ, Phillips D., Hands L., Collin J. Claudication distance is poorly estimated and inappropriately measured. Br J Surg 1997 ; 84: 1107-1109.
21. Gardner AW, Poehlman ET Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995 ; 274: 975-980.
22. Gardner AW, Skinner JS, Cantwell BW, Smith LK Prediction of claudication pain from clinical measurements obtained at rest. Med Sci Sports Exerc 1992 ; 24: 163-170.
23. Regensteiner JG, Hargarten ME, Rutherford RB, Hiatt WR Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication. Angiology 1993 ; 44: 1-10.
24. Johnson EC, Voyles WF, Atterbom HA, Pathak D., Sutton MF, Greene ER Effects of exercise training on common femoral artery blood flow in patients with intermittent claudication. Circulation 1989 ; 80 (5 Pt 2). I1159-72.